Debt-to-equity of THC Therapeutics, Inc. from 31 Jan 2013 to 30 Apr 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
THC Therapeutics, Inc. quarterly Debt-to-equity in % history and change rate from 31 Jan 2013 to 30 Apr 2024.
  • THC Therapeutics, Inc. Debt-to-equity for the quarter ending 30 Apr 2024 was -98%, a 1.8% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

THC Therapeutics, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q1 2024 -98% +2% +1.8% 30 Apr 2024
Q4 2023 -97% +3% +3.1% 31 Jan 2024
Q3 2023 -97% +4% +4.3% 31 Oct 2023
Q2 2023 -98% +6% +5.8% 31 Jul 2023
Q1 2023 -99% +7% +6.8% 30 Apr 2023
Q4 2022 -101% +8% +7.6% 31 Jan 2023
Q3 2022 -102% +10% +8.6% 31 Oct 2022
Q2 2022 -104% +7% +6.1% 31 Jul 2022
Q1 2022 -107% +1% +1.2% 30 Apr 2022
Q4 2021 -109% -2% -1.5% 31 Jan 2022
Q3 2021 -111% -3% -3% 31 Oct 2021
Q2 2021 -111% +5% +3.9% 31 Jul 2021
Q1 2021 -108% -2% -1.7% 30 Apr 2021
Q4 2020 -107% -2% -2.3% 31 Jan 2021
Q3 2020 -108% -6% -5.7% 31 Oct 2020
Q2 2020 -115% +79% +41% 31 Jul 2020
Q1 2020 -106% -388% -138% 30 Apr 2020
Q4 2019 -105% 31 Jan 2020
Q3 2019 -102% 31 Oct 2019
Q2 2019 -194% 31 Jul 2019
Q1 2019 282% 30 Apr 2019
Q1 2014 -404% -662% -257% 30 Apr 2014
Q4 2013 -43008% -43244% -18248% 31 Jan 2014
Q3 2013 536% 31 Oct 2013
Q2 2013 292% 31 Jul 2013
Q1 2013 258% 30 Apr 2013
Q4 2012 237% 31 Jan 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.